Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)

Conditions

• Hepatitis C, Chronic

Interventions

• DRUG: Drug: SCH 900518 Biologic: Peginterferon alfa-2b(PegIntron)
• DRUG: Drug: SCH 900518 Biologic: Peginterferon alfa-2b
• DRUG: Drug: SCH 900518 Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron)
• DRUG: Drug: SCH 900518 Drug: Ritonavir (RTV) Drug: Ritonavir (RTV) Biologic: Peginterferon alfa-2b (PegIntron)

Sponsor

Merck Sharp & Dohme LLC